|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | |||||
| Operating Expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Changes in fair value of warrant liabilities | |||||
| Interest expense | |||||
| Interest income | |||||
| Other income | |||||
| Warrant issuance expense | |||||
| Total other income | |||||
| Loss before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain, change in fair value of available-for-sale securities, net of tax | |||||
| Foreign currency translation gain (loss) | |||||
| Total comprehensive income (loss) | |||||
| Income (loss) per common share attributable to the Company's shareholders | |||||
| Basic income (loss) per common share | |||||
| Diluted loss per common share | |||||
| Weighted-average common shares outstanding - basic | |||||
| Weighted-average common shares outstanding - diluted | |||||
Loading...